Ashley Petrie
Family · Inverness, FLNPI 1306651880
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,742 of the $2,099 with a category attached, or 83.0%. It is spread thinly across 34 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations.
Across 78 payments — averaging $26.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$281
- Incyte Corporation$174
- Merck$135
- Novartis$114
- Johnson & Johnson$111
- Sanofi$96
- plus $1K from 28 others
What the payments were for
- Food & beverage$1,74283%
- Education$35717%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 4 | $281 |
| Incyte Corporation | 7 | $174 |
| Merck | 6 | $135 |
| Novartis | 5 | $114 |
| Johnson & Johnson | 5 | $111 |
| Sanofi | 4 | $96 |
| Seagen Inc. | 1 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Gilead | 3 | $78 |
| E.r. Squibb & Sons, L.L.C. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Lilly USA, LLC | 3 | $77 |
| Bayer | 3 | $67 |
| AstraZeneca(2 entities) | 3 | $60 |
| GSK | 2 | $55 |
| Taiho Oncology, Inc. | 2 | $49 |
| AbbVie | 2 | $44 |
| Novocure Inc. | 1 | $42 |
| Sobi, Inc | 1 | $39 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Eisai Inc. | 2 | $32 |
| Sun Pharmaceutical Industries Inc. | 1 | $30 |
| ADC Therapeutics America, Inc. | 1 | $30 |
| Legend Biotech USA Inc. | 1 | $28 |
| Pharmaessentia USA Corporation | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| EMD Serono, Inc. | 1 | $22 |
| Dendreon Pharmaceuticals LLC | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Teleflex LLC | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
How this compares
$2,099 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Other family in Inverness
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.